[HTML][HTML] Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
D Onan, F Farham, P Martelletti - Toxins, 2024 - mdpi.com
OnabotulinumtoxinA (BT-A) is used in different medical fields for its beneficial effects. BT-A,
a toxin originally produced by the bacterium Clostridium botulinum, is widely known for its …
a toxin originally produced by the bacterium Clostridium botulinum, is widely known for its …
[HTML][HTML] The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis
Botulinum toxin type-A (BoNT-A) has emerged as a key therapeutic agent for the
management of spasticity. This paper presents a comprehensive bibliometric and visual …
management of spasticity. This paper presents a comprehensive bibliometric and visual …
Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study
R David, A Dumas, E Ojardias, S Duval, A Ounajim… - Medicina, 2023 - mdpi.com
Background and Objectives: Botulinum toxin injections are commonly used for the treatment
of spasticity. However, injection procedures are associated with pain and procedural …
of spasticity. However, injection procedures are associated with pain and procedural …
Multiple sclerosis and spasticity: the role of anaesthetic nerve blocks on rectus femoris muscle. When should stiff knee be treated with botulinum toxin?
A Baricich, M Battaglia, MB Borg, A Loro… - Journal of rehabilitation …, 2024 - iris.univr.it
Objective: To compare the effect of rectus femoris diagnostic motor nerve blocks (DNB) with
anaesthetics and rectus femoris muscle botulinum toxin (BoNT-A) injection in multiple …
anaesthetics and rectus femoris muscle botulinum toxin (BoNT-A) injection in multiple …
Setting the Tone for Virtual Spasticity Assessment: Planning Development and Testing of the Telerehabilitation-Objective-Neuromuscular-Evaluation (TONE) Device
DC Gillespie - 2024 - era.library.ualberta.ca
Background: Telehealth provides the ability to connect specialist healthcare providers with
patients regardless of geographical location or other limitations restricting in-person care …
patients regardless of geographical location or other limitations restricting in-person care …
Eficácia e segurança da toxina botulínica no tratamento de indivíduos com paraparesia espástica tropical: um ensaio clínico randomizado duplo-cego e controle …
MS Santos - 2023 - repositorio.ufba.br
Introduction: Myelopathy associated to HTLV-1/tropical spastic paraparesis (HAM/TSP) is a
progressive and disabling disease. Spasticity is one of the main symptoms, in which …
progressive and disabling disease. Spasticity is one of the main symptoms, in which …
Pain Treatment Beyond Spasticity: The Role of AbobotulinumtoxinA in the Rehabilitation of Multiple Sclerosis
Methods In this observational, multicenter, prospective study, subjects were MS patients
undergoing periodical reevaluation and subsequent spasticity treatment with aboBoNT-A …
undergoing periodical reevaluation and subsequent spasticity treatment with aboBoNT-A …
THE USE OF BOTULINUM TOXIN FOR SPASTICITY IN PEOPLE AFFECTED BY SPINAL CORD INJURY: A SCOPING REVIEW PROTOCOL
A Zadra, D Feller, I Maini, M Zarbo, J Bonavita - medRxiv, 2024 - medrxiv.org
Introduction: Up to 80% of individuals affected by Spinal Cord Injury (SCI) develops
spasticity, both in the acute and chronic phases. Botulinum NeuroToxin (BoNT) injections …
spasticity, both in the acute and chronic phases. Botulinum NeuroToxin (BoNT) injections …